Overview Fundamentals API Earnings EOD API Sample Code Pricing

Emyria Ltd (EMD AU) stock market data APIs

A$0.04 0(0%) as of September 19, 2024
Price chart is built with Anychart

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops psychedelic-assisted therapy, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and mild stress and anxiety. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.

Emyria Ltd Financial Data Overview

0.038
0.04
-
0.04
0.038
0.027-0.087
15 542 K
409 M
2 203 K
0.814
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EMD',
Type: 'Common Stock',
Name: 'Emyria Ltd',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG00R41CR37',
ISIN: 'AU0000073645',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Health Information Services',
}

Emyria Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 203 K
  • EBITDA -3 160 181
  • Earnings Per Share -0.03
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Emyria Ltd Earnings via APIs

  • Latest Release 2024-08-30
  • EPS/Forecast NaN

Get Emyria Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com